封面
市场调查报告书
商品编码
1619127

横向流动化验市场规模、份额、成长分析、按产品类型、按方法、按样本类型、按应用、按最终用户、按地区行业预测,2024-2031 年

Lateral Flow Assays Market Size, Share, Growth Analysis, By Product (Kits & Reagents, Readers), By Technique (Sandwich assays, Competitive assays), By Sample Type, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 242 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球横向流动化验市场规模为92亿美元,从2023年的99.1亿美元成长到2031年的179.4亿美元,在预测期内(2024-2031年)预计复合年增长率为7.7。

横向流动化验(LFA) 或免疫测量是使用者友善的诊断工具,对于快速检测目标分析物至关重要,例如食品、水和饲料中的污染物,以及人类和动物病原体和生物标记。 LFA 因其在妊娠检测中的应用而广受认可,也支持传染病检查、药物滥用筛检和快速心臟标记诊断。这些测试不需要水、电或专门培训,并提供快速、经济高效的分析结果。 LFA 具有清晰的测试和控制线,以确保功能性,并且与读取器技术结合时可以量化。其灵活性使得能够在各种环境下就地检验,这对于解决医疗保健准入挑战至关重要,特别是在新兴市场,并且是市场发展的驱动力。

目录

介绍

  • 研究目的
  • 调查范围
  • 定义

调查方法

  • 资讯采购
  • 二手资料和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制因素和挑战
  • 波特分析与影响
    • 竞争公司之间的敌对关係
    • 替代品的威胁
    • 买方议价能力
    • 新进入者的威胁
    • 供应商的议价能力

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2023)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 价格分析
  • 技术进步
  • 监管环境
  • 专利分析
  • 案例研究

横向流动化验市场规模:依产品及复合年增长率(2024-2031)

  • 市场概况
  • 试剂套件和试剂
  • 领导者
    • 数位/手持阅读器
    • 替补最高领导者

横向流动化验市场规模:依技术及复合年增长率(2024-2031)

  • 市场概况
  • 夹心法
  • 竞争性测定
  • 多重检测分析

横向流动化验市场规模:依样本类型及复合年增长率(2024-2031)

  • 市场概况
  • 血液样本
  • 尿液样本
  • 唾液样本
  • 其他样品

横向流动化验市场规模:依应用与复合年增长率(2024-2031)

  • 市场概况
  • 临床检查
    • 传染病检查
    • 心臟标记测试
    • 妊娠及不孕症检测
    • 胆固醇/血脂测试
    • 药物滥用测试
    • 其他实验室测试
  • 兽医诊断
  • 食品安全及环保检验
  • 药品开发与品质检验

横向流动化验市场规模:依最终用户及复合年增长率(2024-2031)

  • 市场概况
  • 医院/诊所
  • 居家照护
  • 诊断实验室
  • 製药和生物技术公司
  • 其他的

横向流动化验市场规模及复合年增长率(2024-2031)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东/非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲

竞争资讯

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2023)
  • 主要企业简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较(2021-2023)

主要企业简介

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • QuidelOrtho Corporation
  • Danaher Corporation
  • Siemens AG
  • Becton, Dickinson and Company
  • Biomerieux SA
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Qiagen NV
  • Merck KGaA
  • Hologic, Inc.
  • Abcam plc
  • Surmodics Inc.
  • Chembio Diagnostics, Inc.(Biosynex)
  • Orasure Technologies
  • DCN Diagnostics
  • Polysciences Inc.
  • Abingdon Health
  • Oranoxis Inc.
  • Aesku.Group GmbH
  • Bio Group Medical System SRL

结论和建议

简介目录
Product Code: SQMIG35A2696

Global Lateral Flow Assays Market size was valued at USD 9.2 billion in 2022 and is poised to grow from USD 9.91 billion in 2023 to USD 17.94 billion by 2031, growing at a CAGR of 7.7% during the forecast period (2024-2031).

Lateral flow assays (LFAs), or immunoassays, are user-friendly diagnostic tools essential for rapid detection of target analytes, including contaminants in food, water, and animal feed, as well as pathogens and biomarkers in humans and animals. Widely recognized for their applications in pregnancy tests, LFAs also cater to infectious disease testing, drug misuse screening, and rapid cardiac marker diagnostics. These tests operate without the need for water, power, or specialized training, offering quick and cost-effective analytical results. LFAs feature clear test and control lines for functionality assurance and can be quantitative when paired with reader technology. Their flexibility enables point-of-care testing across various environments, making them pivotal in addressing healthcare accessibility challenges, particularly in developing regions, thus driving market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lateral Flow Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lateral Flow Assays Market Segmental Analysis

Global Lateral Flow Assays Market is segmented by Product, Technique, Sample Type, Application, End User, and region. Based on Product, the market is segmented into Kits & Reagents, Readers. Based on Technique, the market is segmented into Sandwich assays, Competitive assays, Multiplex detection assays. Based on Sample Type, the market is segmented into Blood samples, Urine samples, Saliva samples, and Other samples. Based on Application, the market is segmented into Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing. Based on End User, the market is segmented into Hospitals & clinics, Home care settings, Diagnostic laboratories, Pharmaceutical & biotechnology companies, and Other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lateral Flow Assays Market

A significant factor driving the growth of the global lateral flow assays market is the increasing adoption of lateral flow devices in home healthcare settings. Their user-friendly nature, portability, and ability to deliver rapid results without requiring additional equipment or medical expertise have led to a surge in the use of these devices since their inception. Additionally, the fact that these tests can be obtained without a prescription is further enhancing their popularity and supporting market growth. Other contributing elements include the presence of reimbursement organizations, funding initiatives, collaborations between major pharmaceutical companies, and ongoing technological advancements, all of which are expected to elevate the demand for lateral flow rapid diagnostic tests.

Restraints in the Global Lateral Flow Assays Market

The growth of the global lateral flow assays market is hindered by several key constraints. One significant issue is the relatively low precision of results produced by lateral flow tests compared to laboratory testing, which medical professionals often prefer due to its higher accuracy. Additionally, the high costs associated with lateral flow assays pose a substantial barrier to market proliferation, particularly in low-income regions. In such areas, limited awareness and a shortage of skilled professionals further exacerbate these challenges, restricting the widespread adoption and acceptance of lateral flow tests and ultimately inhibiting market expansion.

Market Trends of the Global Lateral Flow Assays Market

The Global Lateral Flow Assays market is witnessing remarkable growth driven by the increasing demand for rapid and reliable testing methods across various sectors, particularly in food quality monitoring. As food safety regulations become more stringent due to rising public health concerns over contamination risks from toxins, heavy metals, and adulterants, the adoption of lateral flow assays as "quick tests" is on the rise. Their ability to deliver rapid, single-use results enhances efficiency in detecting contaminants and residues in food products, beverages, and dairy. This trend is further supported by the growing analytical community's preference for simple and cost-effective detection methodologies, positioning lateral flow assays as a pivotal tool in ensuring food safety and quality worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies

Global Lateral Flow Assays Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Kits & Reagents
  • Readers
    • Digital/Handheld Readers
    • Benchtop Readers

Global Lateral Flow Assays Market Size by Technique & CAGR (2024-2031)

  • Market Overview
  • Sandwich assays
  • Competitive assays
  • Multiplex detection assays

Global Lateral Flow Assays Market Size by Sample Type & CAGR (2024-2031)

  • Market Overview
  • Blood samples
  • Urine samples
  • Saliva samples
  • Other samples

Global Lateral Flow Assays Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Clinical Testing
    • Infectious Disease Testing
    • Cardiac Marker Testing
    • Pregnancy & Fertility Testing
    • Cholesterol/Lipid Testing
    • Drugs-of-abuse Testing
    • Other Clinical Tests
  • Veterinary Diagnostics
  • Food Safety & Environment Testing
  • Drug Development & Quality Testing

Global Lateral Flow Assays Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Hospitals & clinics
  • Home care settings
  • Diagnostic laboratories
  • Pharmaceutical & biotechnology companies
  • Other end users

Global Lateral Flow Assays Market Size & CAGR (2024-2031)

  • North America (Product, Technique, Sample Type, Application, End User)
    • US
    • Canada
  • Europe (Product, Technique, Sample Type, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Product, Technique, Sample Type, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Product, Technique, Sample Type, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Technique, Sample Type, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QuidelOrtho Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerieux SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abcam plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Surmodics Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chembio Diagnostics, Inc. (Biosynex)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orasure Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DCN Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Polysciences Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abingdon Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oranoxis Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aesku.Group GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio Group Medical System S.R.L
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation